기본 정보
- 표준 SMILES
Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1- InChIKey
OLXZPDWKRNYJJZ-RRKCRQDMSA-N- 분자식
- C10H13N5O3
- 평균 분자량
- 251.24 g/mol
- 단동위원소 질량
- 251.10183928
개요
2'-deoxyadenosine is a purine 2'-deoxyribonucleoside having adenine as the nucleobase. It has a role as a mouse metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a human metabolite. It is a purines 2'-deoxy-D-ribonucleoside and a purine 2'-deoxyribonucleoside.
이름 및 식별자
- 우선 이름
- Deoxyadenosine
- IUPAC
- (2R,3S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
16373-93-6、40627-14-3、958-09-8- PubChem CID
- 13730
- DTXSID
DTXSID10883624- ChEMBL
CHEMBL449329- ChEBI
CHEBI:17256- UNII
- P582C98ULC
- EC Number
- 213-488-7、683-408-7
- Nikkaji
- J80.042B
물성
구조 계산 물성
- XLogP
- -0.5
- 극성 표면적
- 119 Ų
- 수소 결합 공여자 수
- 3
- 수소 결합 수용자 수
- 7
- 회전 가능 결합 수
- 2
- 무거운 원자 수
- 18
- 형식 전하
- 0
- 복잡도
- 307
실험 및 물리화학적 성질
LogP
-0.55
-0.68
Physical Description
White odorless crystals; [La-Mar-Ka MSDS]
Solid
Collision Cross Section
152.3 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
154.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
160.57 Ų [M-H]- [CCS Type: DT; Method: stepped-field]
151.59 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
155.3 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
158.2 Ų [M+H]+
안전 및 규제
GHS 분류
GHS Classification
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.
This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.
Warning
유해성 정보
Hazard Classes and Categories
Skin Irrit. 2 (75%)
Acute Tox. 3 (100%)
독성 정보
화학 및 산업
약리 정보
MeSH Pharmacological Classification
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.
용도 및 제조
관련 반응
연결된 노트
불러오는 중…